Nobuyuki Matoba

Title: **Nobuyuki Matoba: Innovator in Pharmaceutical Compositions**

Introduction

Nobuyuki Matoba, based in Owensboro, KY, is a distinguished inventor with a noteworthy portfolio comprising ten patents. His innovative contributions primarily lie within the realm of pharmaceutical compositions and formulations, showcasing his commitment to advancing medical treatments.

Latest Patents

Matoba's recent patents include a groundbreaking spray-dried formulation featuring a cholera toxin B subunit variant. This creation involves powder compositions and pharmaceutical combinations that utilize a cholera toxin B subunit variant alongside a saccharide excipient. Additionally, the patents address methods of crafting these powder compositions and outline therapeutic approaches for treating diseases or enhancing wound healing using the developed pharmaceutical compositions.

Another significant contribution from Matoba is related to actinohivin variant polypeptides. This assembly includes polypeptides that can be linked to antibody fragments, such as the fragment crystallizable (Fc) region of immunoglobulin G (IgG). The patents further elaborate on nucleic acid sequences, expression vectors, and transformed plant cells effective for producing these polypeptides. Furthermore, he provides methods for treating viral infections or cancer by administering the actinohivin variant polypeptide to patients.

Career Highlights

Throughout his career, Nobuyuki Matoba has been associated with prominent institutions, including the University of Louisville Research Foundation, Inc. and Arizona State University. His tenure at these research foundations has enabled him to push the boundaries of pharmaceutical innovation.

Collaborations

Working alongside notable colleagues such as Adam Husk and Keegan Baldauf, Matoba has fostered collaborative efforts that have enriched his research. These partnerships underscore the importance of teamwork in cultivating innovative solutions within the scientific community.

Conclusion

Nobuyuki Matoba’s legacy as an inventor is characterized by his dedication to advancing pharmaceutical technologies. His contributions, particularly in cholera toxin formulations and actinohivin variant polypeptides, reflect a pursuit of medical innovation with the potential to enhance treatments for various health conditions. As he continues his work, Matoba exemplifies the spirit of innovation that drives progress in the medical field.